Edition:
United Kingdom

Danaher Corp (DHR.N)

DHR.N on New York Stock Exchange

132.04USD
24 May 2019
Change (% chg)

$0.41 (+0.31%)
Prev Close
$131.63
Open
$132.24
Day's High
$133.23
Day's Low
$131.90
Volume
319,480
Avg. Vol
733,345
52-wk High
$134.67
52-wk Low
$94.62

Latest Key Developments (Source: Significant Developments)

Danaher Sets Regular Quarterly Cash Dividend Of $0.17 Per Share
Friday, 8 Mar 2019 

March 8 (Reuters) - Danaher Corp ::SETS REGULAR QUARTERLY CASH DIVIDEND OF $0.17PER SHARE.  Full Article

Danaher Announces Pricing Of Concurrent Offerings Of 11 Mln Shares At $123/Shr
Wednesday, 27 Feb 2019 

Feb 26 (Reuters) - Danaher Corp ::DANAHER ANNOUNCES PRICING OF COMMON STOCK OFFERING AND MANDATORY CONVERTIBLE PREFERRED STOCK OFFERING.ANNOUNCED THAT IT HAS PRICED CONCURRENT OFFERINGS OF 11 MILLION SHARES AT A PRICE TO PUBLIC OF $123.00 PER SHARE.PRICED 1.5 MILLION SHARES OF 4.75% SERIES A MANDATORY CONVERTIBLE PREFERRED STOCK AT $1,000 PER SHARE.  Full Article

Danaher Says Will Modify Structure Of Dental Unit Spinoff To An IPO
Monday, 25 Feb 2019 

Feb 25 (Reuters) - Danaher Corp ::SAYS WILL MODIFY STRUCTURE OF DENTAL SPINOFF TO AN IPO - CONFERENCE CALL.  Full Article

Danaher To Acquire The Biopharma Business Of General Electric Life Sciences For $21.4 Bln
Monday, 25 Feb 2019 

Feb 25 (Reuters) - Danaher Corp ::DANAHER TO ACQUIRE THE BIOPHARMA BUSINESS OF GENERAL ELECTRIC LIFE SCIENCES FOR $21.4 BILLION.DANAHER CORP - DANAHER EXPECTS TO FINANCE ALL-CASH TRANSACTION WITH APPROXIMATELY $3 BILLION OF PROCEEDS FROM AN EQUITY OFFERING.DANAHER - ESTIMATES DEAL WILL REDUCE GAAP EPS BY APPROXIMATELY $1.15 TO $1.20 BUT WILL BE ACCRETIVE TO NON-GAAP IN FIRST FULL YEAR POST ACQUISITION.DANAHER CORP - NET PURCHASE PRICE IS APPROXIMATELY $20 BILLION.DANAHER CORP - GE BIOPHARMA IS EXPECTED TO GENERATE ANNUAL REVENUE OF APPROXIMATELY $3.2 BILLION IN 2019.DANAHER - BIOPHARMA BUSINESS OF GE LIFE SCIENCES WILL BE ESTABLISHED AS STAND-ALONE OPERATING COMPANY WITHIN DANAHER'S $6.5 BILLION LIFE SCIENCES SEGMENT.DANAHER CORP - EXPECTS TO FINANCE REMAINDER OF DEAL FROM AVAILABLE CASH ON HAND AND PROCEEDS FROM ISSUANCE OF DEBT AND/OR NEW CREDIT FACILITIES.DANAHER - ESTIMATES ACQUISITION WILL BE ACCRETIVE TO ADJUSTED. DILUTED NET EARNINGS PER SHARE BY ABOUT $0.45 TO $0.50 IN FIRST FULL YEAR POST ACQUISITION.  Full Article

GE To Sell Biopharma Business To Danaher For $21.4 Billion
Monday, 25 Feb 2019 

Feb 25 (Reuters) - General Electric Co ::PRESS RELEASE - GE TO SELL BIOPHARMA BUSINESS TO DANAHER FOR $21.4 BILLION.GE - ACCELERATES GE'S STRATEGY TO REDUCE LEVERAGE AND STRENGTHEN BALANCE SHEET.GE - DEAL EXPECTED TO CLOSE IN Q4 OF 2019.GE - DEAL FOR $21.4 BILLION, INCLUDING $21 BILLION IN CASH AS WELL AS DANAHER'S ASSUMPTION OF CERTAIN PENSION LIABILITIES.GE - BIOPHARMA BUSINESS BEING DIVESTED IS PART OF GE LIFE SCIENCES.GE - TRANSACTION IS NOT SUBJECT TO A FINANCING CONDITION OR A SHAREHOLDER VOTE..GE - PHARMACEUTICAL DIAGNOSTICS, CURRENTLY PART OF GE LIFE SCIENCES, WILL REMAIN WITHIN GE HEALTHCARE PORTFOLIO.GE - PHARMACEUTICAL DIAGNOSTICS, CURRENTLY PART OF GE LIFE SCIENCES, WILL REMAIN WITHIN GE HEALTHCARE PORTFOLIO.GE - EXPECTS TO USE PROCEEDS FROM TRANSACTION TO REDUCE LEVERAGE AND STRENGTHEN BALANCE SHEET.  Full Article

Danaher Reports Q4 Adjusted Earnings Per Share $1.28
Tuesday, 29 Jan 2019 

Jan 29 (Reuters) - Danaher Corp ::DANAHER REPORTS FOURTH QUARTER AND FULL YEAR 2018 RESULTS.SEES Q1 2019 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.00 TO $1.03.SEES FY 2019 ADJUSTED NON-GAAP EARNINGS PER SHARE $4.75 TO $4.85.SEES Q1 2019 EARNINGS PER SHARE $0.78 TO $0.81.SEES FY 2019 EARNINGS PER SHARE $3.85 TO $3.95.Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.28.Q4 EARNINGS PER SHARE $1.05.Q4 REVENUE $5.4 BILLION VERSUS REFINITIV IBES ESTIMATE OF $5.32 BILLION.Q4 EARNINGS PER SHARE ESTIMATE $1.27 -- REFINITIV IBES DATA.Q1 EARNINGS PER SHARE VIEW $1.03 -- REFINITIV IBES DATA.FY2019 EARNINGS PER SHARE VIEW $4.81 -- REFINITIV IBES DATA.  Full Article

Danaher CEO To Comment On Financial Performance
Tuesday, 8 Jan 2019 

Jan 7 (Reuters) - Danaher Corp ::DANAHER CEO TO COMMENT ON FINANCIAL PERFORMANCE.JOYCE WILL COMMUNICATE THAT Q4 2018 CORE REVENUE GROWTH IS EXPECTED TO BE ABOVE COMPANY'S PREVIOUSLY ANNOUNCED GUIDANCE.JOYCE WILL COMMUNICATE THAT Q4 ADJUSTED EARNINGS PER SHARE EXPECTED TO BE AT OR NEAR HIGH-END OF CO'S PREVIOUSLY ANNOUNCED GUIDANCE.  Full Article

Danaher Sees FY 2019 EPS Of $4.02 To $4.12
Thursday, 13 Dec 2018 

Dec 13 (Reuters) - Danaher Corp ::DANAHER INITIATES 2019 OUTLOOK.SEES FY 2019 EARNINGS PER SHARE $4.02 TO $4.12.SEES FY 2019 ADJUSTED NON-GAAP EARNINGS PER SHARE $4.75 TO $4.85.COMPANY ANTICIPATES THAT 2019 DILUTED NET EARNINGS PER SHARE WILL BE IN RANGE OF $4.02 TO $4.12.2019 NON-GAAP ADJUSTED DILUTED NET EARNINGS PER SHARE GUIDANCE ASSUMES NON-GAAP CORE REVENUE GROWTH OF APPROXIMATELY 4%.FY2019 EARNINGS PER SHARE VIEW $4.84 -- REFINITIV IBES DATA.  Full Article

Danaher Reports Q3 Adjusted Earnings Per Share $1.10
Thursday, 18 Oct 2018 

Oct 18 (Reuters) - Danaher Corp ::DANAHER REPORTS THIRD QUARTER 2018 RESULTS.SEES Q4 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.25 TO $1.28.SEES Q4 2018 EARNINGS PER SHARE $1.04 TO $1.07.Q3 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.10.Q3 EARNINGS PER SHARE $0.93.Q3 REVENUE $4.9 BILLION VERSUS I/B/E/S VIEW $4.8 BILLION.Q3 EARNINGS PER SHARE VIEW $1.08 -- THOMSON REUTERS I/B/E/S.RAISES FY 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE VIEW TO $4.49 TO $4.52.RAISES FY 2018 EARNINGS PER SHARE VIEW TO $3.72 TO $3.75.Q4 EARNINGS PER SHARE VIEW $1.28 -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $4.49 -- THOMSON REUTERS I/B/E/S.  Full Article

Danaher Q2 Earnings Per Share $0.95
Thursday, 19 Jul 2018 

July 19 (Reuters) - Danaher Corp ::DANAHER REPORTS SECOND QUARTER 2018 RESULTS.SEES Q3 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.05 TO $1.08.SEES FY 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE $4.43 TO $4.50.SEES Q3 2018 EARNINGS PER SHARE $0.85 TO $0.88.SEES FY 2018 EARNINGS PER SHARE $3.64 TO $3.71.Q2 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.15.Q2 EARNINGS PER SHARE $0.95.Q2 REVENUE $5.0 BILLION VERSUS I/B/E/S VIEW $4.92 BILLION.Q2 EARNINGS PER SHARE VIEW $1.09 -- THOMSON REUTERS I/B/E/S.Q3 EARNINGS PER SHARE VIEW $1.08, REVENUE VIEW $4.85 BILLION -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $4.44, REVENUE VIEW $19.81 BILLION -- THOMSON REUTERS I/B/E/S.FY2018 EARNINGS PER SHARE VIEW $4.44 -- THOMSON REUTERS I/B/E/S.  Full Article

Colfax nears deal to sell air and gas unit to KPS -sources

May 12 Welding and valves manufacturer Colfax Corp is nearing a deal to sell its air and gas handling division to private equity firm KPS Capital Partners for more than $1.8 billion, people familiar with the matter said on Sunday.